Dr. Reddy’s launches private label version of allergy remedy Xyzal
Princeton, N.J.-based Dr. Reddy’s Laboratories last week launched levocetirizine dihydrochloride tablets USP, 5 mg, an over-the-counter therapeutic equivalent private label version of Sanofi Consumer Health's Xyzal Allergy 24HR Tablets in the United States market as approved by the U.S. Food and Drug Administration.
"This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” Milan Kalawadia, vice president and head, U.S. OTC and speciality Rx businesses, Dr. Reddy’s Laboratories, said. “We look forward to collaborating with our customers to bring high-quality, affordable store brand alternatives to the market.”
The Xyzal generic equivalent is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. The branded Xyzal Allergy 24HR Tablets had U.S. sales of approximately $71 million for the most recent 12 months ending in January 2018 according to IRI, Dr. Reddy's reported.
"This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” Milan Kalawadia, vice president and head, U.S. OTC and speciality Rx businesses, Dr. Reddy’s Laboratories, said. “We look forward to collaborating with our customers to bring high-quality, affordable store brand alternatives to the market.”
The Xyzal generic equivalent is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. The branded Xyzal Allergy 24HR Tablets had U.S. sales of approximately $71 million for the most recent 12 months ending in January 2018 according to IRI, Dr. Reddy's reported.